THE WIRE
What insiders and companies just did: insiders buying and selling with their own money, company news, new 5% stakes and new shares registered.
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Key
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Newest first. Insider rows are open-market purchases and sales; several by one company are one row, open it for each.
- ALXOAlx Oncology Holdings IncResults of operations.+1.9%8-K 2.02 ↗
- NWSNews CorpOther events.−6.7%8-K 8.01 ↗
- CRBPCorbus Pharmaceuticals Holdings, IncRegulation FD disclosure and other events.−39.2%8-K 7.01 ↗
- MOVECorvex, IncRegulation FD disclosure and other events.
3-Year Agreement Will More than Double Mid-Atlantic 1 Contracted Annual Recurring Revenue from $22 Million to Approximately $56 Million Customer Prepayment and Debt Financing Fund More Than 80% of…
−26.8%8-K 7.01 ↗ - IAMIambic Therapeutics, IncResults of operations.8-K 2.02 ↗
- LKQLKQ CorpOfficer or director change.−3.4%8-K 5.02 ↗
- DFDVDeFi Development CorpOther events.
DeFi Development Corp. Records Ten Straight Weeks of SOL Treasury Growth; CHAD Extends Daily Dividend Track Record SOL Treasury Reaches 2.62 Million Following Addition of 9,482 SOL and SOL…
−28.8%8-K 8.01 ↗ - OBAIOur Bond, IncMaterial agreement and unregistered sale of shares.−27.9%8-K 1.01 ↗
- APMDApnimed, IncResults of operations.−4.9%8-K 2.02 ↗
- ACCVAccelevation Holdings CorpResults of operations (amended).8-K/A 2.02 ↗
- NMRANeumora Therapeutics, IncResults of operations.
Neumora Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update IND application for NMRA-215 (NLRP3 inhibitor) submitted to the U.S. Food and Drug Administration…
−22.1%8-K 2.02 ↗ - ADGMAdagio Medical Holdings, IncResults of operations.
Adagio Medical Reports Third Quarter 2026 Results
−9.3%8-K 2.02 ↗ - DMRCDigimarc CorpMaterial agreement and officer or director change.
Digimarc - Cooperation Agreement Press Release Digimarc Announces Board Refreshment to Build on Strategic Transformation and Support Next Phase of Growth Dris Upitis, Amy O ’ Keefe, and Kevin…
−22.2%8-K 1.01 ↗ - VENUVenu Holding CorpResults of operations.
Venu Holding Corporation Reports Third Quarter Fiscal 2026 Financial Results Total Assets Increased $217.1 million to $587.6 million, Up 59% from Year-End 2025
−12.1%8-K 2.02 ↗ - POWWOutdoor Holding CoResults of operations.
Outdoor Holding Company Reports Second Quarter Fiscal 2027 Financial Results Revenue increased 14.6% to $13.7 million and net income from continuing operations increased to $2.3 million; first-half…
+12.7%8-K 2.02 ↗ - SLESuper League Enterprise, IncOther events.−20.0%8-K 8.01 ↗
- PLCEChildrens Place, IncMaterial agreement and new debt or obligation.+20.7%8-K 1.01 ↗
- KTTAPasithea Therapeutics CorpRegulation FD disclosure.−8.3%8-K 7.01 ↗
- RLMDRelmada Therapeutics, IncRegulation FD disclosure.
Relmada Therapeutics Appoints Uro-Oncology Leader Jørn Skibsted Jakobsen, MD, PhD, as Chief Development Officer Former ADSTILADRIN® global clinical development leader brings extensive uro-oncology…
−37.8%8-K 7.01 ↗ - JSPRJasper Therapeutics, IncResults of operations.
Jasper Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
−36.5%8-K 2.02 ↗ - MSTRStrategy IncRegulation FD disclosure and other events.−30.3%8-K 7.01 ↗
- ANIPAni Pharmaceuticals IncRegulation FD disclosure.−4.0%8-K 7.01 ↗
- OPTUOptimum Communications, IncDebt obligation accelerated.+15.6%8-K 2.04 ↗
- ASSTStrive, IncOther events.−32.1%8-K 8.01 ↗
- WMTWalmart IncOfficer or director change.
Walmart Walmart names Joe Creed to Board of Directors
−0.1%8-K 5.02 ↗ - GALTGalectin Therapeutics IncResults of operations.
Galectin Therapeutics Reports September 30, 2026 Financial Results and Provides Business Update
−11.8%8-K 2.02 ↗ - ABCBAmeris BancorpRegulation FD disclosure.
AMERIS BANCORP ENHANCES CENTRAL FLORIDA PRESENCE THROUGH AGREEMENT TO ACQUIRE BANK OF CENTRAL FLORIDA HOLDING COMPANY
−4.0%8-K 7.01 ↗ - LNZALanzaTech Global, IncResults of operations.
LanzaTech Reports Third Quarter 2026 Financial Results Significant progress against cost reduction efforts positions business for sustained success LanzaTech achieves world's first ISCC EU…
−24.9%8-K 2.02 ↗ - SGRYSurgery Partners, IncRegulation FD disclosure.−0.6%8-K 7.01 ↗
- MNTKMontauk Renewables, IncOfficer or director change.+19.5%8-K 5.02 ↗
- MNTKMontauk Renewables, IncResults of operations.
Montauk Renewables Announces Third Quarter 2026 Results
+19.5%8-K 2.02 ↗ - CREXCreative Realities, IncResults of operations.
Creative Realities Reports Fiscal 2026 Third Quarter Results Revenue $26.2 Million, on Track for Record-Setting Year, Strong Outlook for 2027
+0.2%8-K 2.02 ↗ - CNSYCerenome, IncOther events.
Cerenome Reports Interim ReSPECT-LM Data Supporting Repeat Dosing of REYOBIQ ™ in Leptomeningeal Metastases at the 2026 SNO Annual Meeting No dose-limiting toxicities in the first 10 patients…
−33.7%8-K 8.01 ↗ - MARAMARA Holdings, IncOther events.−27.3%8-K 8.01 ↗
- TSNTyson Foods, IncResults of operations.
TYSON FOODS REPORTS FOURTH QUARTER AND FISCAL 2026 RESULTS Prepared Foods Growth and Chicken Resilience Bolster Performance
+10.7%8-K 2.02 ↗ - EDBLEdible Garden AG IncResults of operations.−29.7%8-K 2.02 ↗
- VIDAVIDA Global IncResults of operations and Regulation FD disclosure.
Vida Global Announces Third Quarter 2026 Financial Results
−28.4%8-K 2.02 ↗ - CTRECareTrust REIT, IncRegulation FD disclosure.−3.5%8-K 7.01 ↗
- MDCXMedicus Pharma LtdMaterial agreement and unregistered sale of shares.−41.8%8-K 1.01 ↗
- MBRXMoleculin Biotech, IncResults of operations.
New preclinical findings suggest Annamycin may help turn immunologically “cold” pancreatic tumors “hot,” supporting potential combination treatment approaches
−1.7%8-K 2.02 ↗ - MACMacerich CoRegulation FD disclosure and other events.−6.8%8-K 7.01 ↗
- MPLTMapLight Therapeutics, IncResults of operations and Regulation FD disclosure.−18.1%8-K 2.02 ↗
- XTNDXtend AI Robotics, IncResults of operations.+18.7%8-K 2.02 ↗
- LRMRLarimar Therapeutics, IncResults of operations.+4.0%8-K 2.02 ↗
- PRLDPrelude Therapeutics IncResults of operations and Regulation FD disclosure.−6.4%8-K 2.02 ↗
- IVVDInvivyd, IncResults of operations.−29.1%8-K 2.02 ↗
- CYPHCypherpunk Technologies IncResults of operations.−24.6%8-K 2.02 ↗
- NSPRInspireMD, IncMaterial agreement and other events.
InspireMD Announces Pricing of $37.5 Million Public Offering
−16.2%8-K 1.01 ↗ - XTNTXtant Medical Holdings, IncResults of operations.
Medical Reports Third Quarter 2026 Financial Results and Announces Board-led Strategic Review Process Board reiterates commitment to improving performance and maximizing stockholder value; has been…
−22.2%8-K 2.02 ↗ - AIRJAirJoule Technologies CorpResults of operations and officer or director change.
AirJoule Technologies Reports Third Quarter 2026 Results and Provides Preliminary 2027 BitSink Outlook • Completes BitSink Acquisition and Sharpens Commercial Focus on Highest-Value Applications for…
−27.9%8-K 2.02 ↗